ProfileGDS4284 / 227461_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 12% 31% 19% 9% 39% 35% 36% 33% 42% 6% 76% 30% 38% 18% 32% 37% 54% 48% 37% 38% 30% 43% 34% 40% 28% 28% 37% 22% 37% 29% 7% 23% 39% 38% 37% 29% 44% 37% 31% 54% 5% 9% 30% 39% 15% 18% 37% 35% 72% 57% 60% 43% 44% 70% 42% 54% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control17.906912
GSM687648Patient 402 control80.77131
GSM687653Patient 403 control35.41519
GSM687658Patient 404 control15.86849
GSM687663Patient 411 control137.94439
GSM687668Patient 422 control102.32135
GSM687673Patient 424 control118.9536
GSM687678Patient 425 control101.47133
GSM687683Patient 427 control159.6942
GSM687688Patient 428 control10.6146
GSM687695Patient 441 control1042.676
GSM687699Patient 443 control96.400130
GSM687704Patient 444 control117.73838
GSM687707Patient 448 control41.791518
GSM687712Patient 449 control89.024532
GSM687719Patient 450 control142.02637
GSM687724Patient 451 control289.27254
GSM687728Patient 452 control210.73848
GSM687646Patient 401 treated 24h115.25337
GSM687649Patient 402 treated 24h106.20738
GSM687665Patient 411 treated 24h86.222230
GSM687651Patient 402 treated 4 weeks160.47543
GSM687667Patient 411 treated 4 weeks102.02534
GSM687670Patient 422 treated 24h144.84940
GSM687671Patient 422 treated 4 weeks69.204928
GSM687654Patient 403 treated 24h61.393928
GSM687675Patient 424 treated 24h130.99337
GSM687685Patient 427 treated 24h46.128722
GSM687656Patient 403 treated 4 weeks100.02337
GSM687677Patient 424 treated 4 weeks72.69629
GSM687687Patient 427 treated 4 weeks10.04747
GSM687692Patient 428 treated 4h49.520123
GSM687716Patient 449 treated 4h124.95939
GSM687722Patient 450 treated 4h143.5838
GSM687680Patient 425 treated 24h114.80637
GSM687690Patient 428 treated 24h72.507529
GSM687700Patient 443 treated 24h237.70344
GSM687705Patient 444 treated 24h108.85737
GSM687714Patient 449 treated 24h77.173931
GSM687721Patient 450 treated 24h320.8554
GSM687682Patient 425 treated 4 weeks9.717355
GSM687694Patient 428 treated 4 weeks13.11869
GSM687702Patient 443 treated 4 weeks85.788730
GSM687718Patient 449 treated 4 weeks131.22739
GSM687723Patient 450 treated 4 weeks28.635315
GSM687661Patient 404 treated 4h35.935218
GSM687710Patient 448 treated 4h113.16937
GSM687726Patient 451 treated 4h123.57435
GSM687730Patient 452 treated 4h940.91272
GSM687660Patient 404 treated 24h357.48557
GSM687697Patient 441 treated 24h459.97960
GSM687709Patient 448 treated 24h167.6543
GSM687725Patient 451 treated 24h197.73944
GSM687729Patient 452 treated 24h700.55770
GSM687727Patient 451 treated 4 weeks171.89842
GSM687731Patient 452 treated 4 weeks303.954